|
Report No. : |
337631 |
|
Report Date : |
25.08.2015 |
IDENTIFICATION DETAILS
|
Name : |
GLAXOSMITHKLINE DUNGARVAN LIMITED |
|
|
|
|
Formerly Known As : |
BUTFORD LIMITED |
|
|
|
|
Registered Office : |
Knockbrack, Dungarvan, Co Waterford, 222817 |
|
|
|
|
Country : |
Ireland |
|
|
|
|
Date of Incorporation : |
05.07.1997 |
|
|
|
|
Legal Form : |
Not Available |
|
|
|
|
Line of Business : |
|
|
|
|
|
No. of Employee : |
Not Available |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
No complaints |
|
|
|
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made on
e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31, 2015
|
Country Name |
Previous Rating (31.12.2014) |
Current Rating (31.03.2015) |
|
Ireland |
A2 |
A2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
IRELAND - ECONOMIC OVERVIEW
Ireland is a small, modern, trade-dependent economy. Ireland was among the initial group of 12 EU nations that began circulating the euro on 1 January 2002. GDP growth averaged 6% in 1995-2007, but economic activity dropped sharply during the world financial crisis and the subsequent collapse of its domestic property market and construction industry. Faced with sharply reduced revenues and a burgeoning budget deficit from efforts to stabilize its fragile banking sector, the Irish Government introduced the first in a series of draconian budgets in 2009. These measures were not sufficient to stabilize Ireland’s public finances. In 2010, the budget deficit reached 32.4% of GDP - the world's largest deficit, as a percentage of GDP. In late 2010, the former COWEN government agreed to a $92 billion loan package from the EU and IMF to help Dublin recapitalize Ireland’s banking sector and avoid defaulting on its sovereign debt. In March 2011, the KENNY government intensified austerity measures to meet the deficit targets under Ireland's EU-IMF bailout program. In late 2013, Ireland formally exited its EU-IMF bailout program, benefiting from its strict adherence to deficit-reduction targets and success in refinancing a large amount of banking-related debt. In 2014, the economy rapidly picked up and GDP grew by 3.6%. The recovering economy assisted lowering the deficit to 4.2% of GDP. In late 2014, the government introduced a fiscally neutral budget, marking the end of the austerity program. In the wake of the collapse of the construction sector and the downturn in consumer spending and business investment, the export sector, dominated by foreign multinationals, has become an even more important component of Ireland's economy. Ireland’s low corporation tax of 12.5% has been central to encouraging business investment. Loose tax residency requirements made Ireland a common destination for international firms seeking to avoid taxation. Amid growing international pressure the government announced it would phase in more stringent tax laws, effectively closing a loophole.
|
Source
: CIA |
GLAXOSMITHKLINE
DUNGARVAN LIMITED
KNOCKBRACK
DUNGARVAN
CO WATERFORD
222817
|
Registered Address |
KNOCKBRACK |
Trading Address |
KNOCKBRACK |
|
|
DUNGARVAN |
|
DUNGARVAN |
|
|
CO WATERFORD |
|
CO WATERFORD |
|
|
222817 |
|
CO WATERFORD |
|
Website Address |
- |
|
|
|
Telephone Number |
05822500 |
Fax Number |
|
|
TPS |
No |
FPS |
No |
|
Incorporation Date |
05/07/1997 |
|
|
|
Previous Name |
BUTFORD LIMITED |
Type |
Other |
|
|
|
FTSE Index |
- |
|
Date of Change |
- |
Filing Date
of Accounts |
- |
|
Currency |
EUR |
Share Capital |
€750,000 |
|
SIC07 |
21200 |
Charity Number |
- |
|
SIC07 Description |
MANUFACTURE OF PHARMACEUTICAL
PREPARATIONS |
|
|
|
Principal Activity |
The manufacture and sale
of pharmaceutical products. |
|
|
Year to Date Turnover
Pre Tax Profit Shareholder
Funds Employees
31/12/2013 - - - -
31/12/2012 - - - -
31/12/2011 - - - -
|
Total Mortgage |
0 |
|
Outstanding |
0 |
|
Satisfied |
0 |
|
Total Number
of Documented Trade |
0 |
|
Total Value
of Documented Trade |
€0 |
|
Commentary |
|
No comments to display |
CJ
|
|
||
|
Total Number
of Exact CJs - |
0 |
Total Value
of Exact CJs - |
€0 |
|
Total Number
of Possible CJs - |
0 |
Total Value
of Possible CJs - |
€0 |
|
Total Number
of Satisfied CJs - |
0 |
Total Value
of Satisfied CJs - |
€0 |
|
Total Current Directors |
6 |
|
Total Current Secretaries |
1 |
|
Total Previous Directors /
Company Secretaries |
12 |
|
Name |
NICHOLAS COMYN |
Date of
Birth |
02/04/1946 |
|
Officers
Title |
|
Nationality |
|
|
Present
Appointments |
36 |
Function |
Director |
|
Appointment
Date |
17/12/2009 |
|
|
|
Address |
10 SHELDON, ST PATRICKS HILL, CO. CORK. |
|
|
|
Name |
DECLAN BAILEY |
Date of
Birth |
25/07/1965 |
|
Officers
Title |
|
Nationality |
|
|
Present
Appointments |
1 |
Function |
Director |
|
Appointment
Date |
19/05/2003 |
|
|
|
Address |
WHELAN'S BRIDGE, KILMEADEN, CO. WATERFORD. |
|
|
|
Name |
PADRAIC JOHN DOHERTY |
Date of
Birth |
08/11/1971 |
|
Officers
Title |
|
Nationality |
|
|
Present
Appointments |
3 |
Function |
Director |
|
Appointment
Date |
10/02/2015 |
|
|
|
Address |
DROMINA, WOODSTOWN, CO. WATERFORD. |
|
|
|
Name |
PATRICK CORKERY |
Date of
Birth |
10/01/1976 |
|
Officers
Title |
|
Nationality |
|
|
Present
Appointments |
2 |
Function |
Director |
|
Appointment
Date |
24/03/2009 |
|
|
|
Address |
GLENDINE, YOUGHAL, CO. CORK. |
|
|
|
Name |
FRANK O'ROURKE |
Date of
Birth |
27/10/1960 |
|
Officers
Title |
|
Nationality |
|
|
Present
Appointments |
1 |
Function |
Director |
|
Appointment
Date |
26/08/2009 |
|
|
|
Address |
11 STRANDSIDE, ABBEYSIDE, DUNGARVAN, CO. WATERFORD. |
|
|
|
Name |
PAT MCLOUGHLIN |
Date of
Birth |
26/04/1972 |
|
Officers
Title |
|
Nationality |
|
|
Present
Appointments |
2 |
Function |
Director |
|
Appointment
Date |
30/06/2014 |
|
|
|
Address |
CARROWSTEELAUN, CLAREMORRIS, CO MAYO |
|
|
|
Current
Company Secretary |
|
|
|
|
Name |
R.D.J. LIMITED |
Date of
Birth |
- |
|
Officers
Title |
|
Nationality |
|
|
Present
Appointments |
2 |
Function |
Company Secretary |
|
Appointment
Date |
17/12/2009 |
|
|
|
Address |
2 PARK PLACE, CITYGATE PARK, MAHON, CORK |
|
|
|
Name |
Currency |
Share Count |
Share Type |
Nominal Value |
% of Total
Share Count |
|
SETFIRST LTD |
EUR |
600,000 |
ORDINARY |
1.25 |
100 |
|
Date Of |
31/12/13(%) |
31/12/12(%) |
31/12/11(%) |
31/12/10(%) |
31/12 |
|
||||||
|
Accounts |
|
|||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Weeks |
|
52 (%) |
52 (%) |
52 (%) |
52 (%) |
52 |
|
|||||
|
|
|
|
|
|
|
|
|
|
||||
|
Currency |
|
EUR (%) |
EUR (%) |
EUR (%) |
EUR (%) |
EUR |
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Consolidated |
N |
(%) |
N |
(%) |
N |
(%) |
N |
(%) |
N |
|
||
|
A/cs |
|
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Turnover |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Export |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of
Sales |
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross Profit |
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Wages & |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
|
|
Salaries |
|
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Directors |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
|
|
Emoluments |
|
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
Operating Profit- |
- |
- |
- |
- |
- |
- |
- |
- |
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation |
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Audit Fees |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
|
|
Payments |
|
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
Pre Tax
Profit - |
- |
- |
- |
- |
- |
- |
- |
- |
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Taxation |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
Profit After
Tax- |
- |
- |
- |
- |
- |
- |
- |
- |
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividends |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
|
|
Payable |
|
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
Retained Profit
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Date Of |
31/12/13(%) |
31/12/12(%) |
31/12/11(%) |
31/12/10(%) |
31/12 |
|
|||||||||||||
|
Accounts |
|
||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
Tangible Assets0 |
- |
0 |
- |
0 |
- |
0 |
- |
0 |
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
Intangible |
|
0 |
- |
0 |
- |
0 |
- |
0 |
- |
0 |
|
||||||||
|
Assets |
|
|
|||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
Total Fixed |
|
0 |
- |
0 |
- |
0 |
- |
0 |
- |
0 |
|
||||||||
|
Assets |
|
|
|||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
Stock |
|
0 |
- |
0 |
- |
0 |
- |
0 |
- |
0 |
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Trade Debtors |
0 |
- |
0 |
- |
0 |
- |
0 |
- |
0 |
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
Cash |
|
0 |
- |
0 |
- |
0 |
- |
0 |
- |
0 |
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Other Debtors |
0 |
- |
0 |
- |
0 |
- |
0 |
- |
0 |
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Miscellaneous |
0 |
- |
0 |
- |
0 |
- |
0 |
- |
0 |
|
|||||||||
|
Current Assets |
|
||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Total Current |
0 |
- |
0 |
- |
0 |
- |
0 |
- |
0 |
|
|||||||||
|
Assets |
|
|
|||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
Trade Creditors0 |
- |
0 |
- |
0 |
- |
0 |
- |
0 |
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Bank Loans
& |
0 |
- |
0 |
- |
0 |
- |
0 |
- |
0 |
|
|||||||||
|
Overdrafts |
|
|
|||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
Other Short
Term |
- |
0 |
- |
0 |
- |
0 |
- |
0 |
|
||||||||||
|
Finance |
|
0 |
|
||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Miscellaneous |
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Current |
|
0 |
- |
0 |
- |
0 |
- |
0 |
- |
0 |
|
||||||||
|
Liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
Total Current |
|
0 |
- |
0 |
- |
0 |
- |
0 |
- |
0 |
|
||||||||
|
Liabilities |
|
|
|
||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
Bank Loans
& |
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
Overdrafts and |
|
0 |
- |
0 |
- |
0 |
- |
0 |
- |
0 |
|
||||||||
|
LTL |
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Other Long
Term |
0 |
- |
0 |
- |
0 |
- |
0 |
- |
0 |
|
|||||||||
|
Finance |
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
Total Long
Term |
0 |
- |
0 |
- |
0 |
- |
0 |
- |
0 |
|
|||||||||
|
Liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
. |
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
Date Of |
31/12/13(%) |
31/12/12(%) |
31/12/11(%) |
31/12/10(%) |
31/12 |
|
|||||||
|
Accounts |
|
||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
Called Up
Share - |
- |
- |
- |
- |
- |
- |
- |
- |
|
||||
|
Capital |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
P &
L Account |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
||
|
Reserve |
|
|
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revaluation |
|
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
|
|
Reserve |
|
|
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sundry |
|
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
|
|
Reserves |
|
|
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shareholder |
|
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
|
|
Funds |
|
|
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Date Of |
31/12/13(%) |
31/12/12(%) |
31/12/11(%) |
31/12/10(%) |
31/12 |
|
|||||||
|
Accounts |
|
||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Worth |
|
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
Working Capital
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Assets |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
Total Liabilities- |
- |
- |
- |
- |
- |
- |
- |
- |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Assets |
|
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Date Of |
31/12/13(%) |
31/12/12(%) |
31/12/11(%) |
31/12/10(%) |
31/12 |
|
|||||||
|
Accounts |
|
||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Cashflow |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
from Operations - |
- |
- |
- |
- |
- |
- |
- |
- |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Cashflow |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
||
|
|
|
|
|
||||||||||
|
before Financing |
|
|
|
|
|
|
|
|
|
|
|||
|
Net Cashflow |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
||
|
from Financing |
|
|
|||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Increase in |
|
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
|
|
Cash |
|
|
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
Date Of |
31/12/13(%) |
31/12/12(%) |
31/12/11(%) |
31/12/10(%) |
31/12 |
|
|||||||
|
Accounts |
|
||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Contingent |
|
NO |
- |
NO |
- |
NO |
- |
NO |
- |
NO |
|
||
|
Liability |
|
|
|||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Capital |
|
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
|
|
Employed |
|
|
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of |
|
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
|
|
Employees |
|
|
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accountants
AuditorsPRICEWATERHOUSECOOPERS LLP
Auditor
The audit report contains no adverse comments Comments
Bankers ALLIED IRISH BANK
Bank Branch
Code
|
Date Of |
31/12/13 |
31/12/12 |
31/12/11 |
31/12/10 |
31/12 |
|
||
|
Accounts |
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pre-tax profit |
|
- |
- |
- |
- |
- |
|
|
|
margin % |
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current ratio |
|
- |
- |
- |
- |
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales/Net |
|
- |
- |
- |
- |
- |
|
|
|
Working Capital |
|
|||||||
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
Gearing % |
|
0 |
0 |
0 |
0 |
0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity in
% |
|
- |
- |
- |
- |
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
Creditor Days |
|
- |
- |
- |
- |
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
Debtor Days |
|
- |
- |
- |
- |
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
Liquidity/Acid |
|
- |
- |
- |
- |
- |
|
|
|
Test |
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Return On |
|
|
|
|
|
|
|
|
|
Capital |
|
- |
- |
- |
- |
- |
|
|
|
Employed % |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Return On
Total |
|
|
|
|
|
|
|
|
|
Assets |
|
- |
- |
- |
- |
- |
|
|
|
Employed % |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current Debt |
|
- |
- |
- |
- |
- |
|
|
|
Ratio |
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Debt
Ratio |
- |
- |
- |
- |
- |
|
||
|
|
|
|
|
|
|
|
|
|
|
Stock Turnover |
|
- |
- |
- |
- |
- |
|
|
|
Ratio % |
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Return on
Net |
|
|
|
|
|
|
|
|
|
Assets |
|
- |
- |
- |
- |
- |
|
|
|
Employed % |
|
|
|
|
|
|
|
|
|
Date |
|
Previous Name |
|
N/A |
|
BUTFORD LIMITED |
|
05/07/1997 |
|
SMITHKLINE BEECHAM DUNGARVAN LIMITED |
Received Documents
Writ Details
No writs found
|
Statistics |
|
Summary |
|
|
Group |
105 companies |
Holding Company |
SETFIRST LIMITED |
|
Linkages |
148 companies |
Ownership Status |
Wholly Owned |
|
Countries |
In 48 countries |
Ultimate Holding
Company |
GLAXOSMITHKLINE PLC |
|
Company Name |
Registered |
Latest Key |
Consol. |
Turnover |
|
|
Number |
Financials |
Accounts |
|
|
GLAXOSMITHKLINE PLC |
03888792 |
31.12.2014 |
Y |
£100,000,000£23,006,000,000 |
|
GLAXOSMITHKLINE MERCUR... |
07004253 |
31.12.2014 |
N |
£100,000,000 |
|
VIIV HEALTHCARE LIMITED |
06876960 |
31.12.2014 |
Y |
£1,465,940,000 |
|
PHIVCO UK LIMITED |
06944223 |
31.12.2014 |
N |
|
|
PHIVCO UK II LIMITED |
06944229 |
31.12.2014 |
N |
£86,614,000 |
|
VIIV HEALTHCARE TR... |
06982415 |
31.12.2014 |
N |
£917,178,000 |
|
VIIV HEALTHCARE UK... |
06990358 |
31.12.2014 |
N |
£463,948,000 |
|
VIIV HEALTHCARE U... |
08270754 |
31.12.2013 |
N |
|
|
VIIV HEALTHCARE OV... |
07027385 |
31.12.2014 |
N |
£19,000 |
|
ALBERTA ULC |
N/A |
- |
- |
|
|
STIEFEL LABORATORIES... |
IE049850 |
31.12.2013 |
N |
|
|
STIEFEL DISTRIBUTO... |
IE156130 |
31.03.2014 |
N |
|
|
STIEFEL LABORATORI... |
FC017829 |
31.03.2005 |
Y |
£114,013,000 |
|
STIEFEL LABORATOR... |
05354860 |
31.12.2013 |
N |
£10,207,000 |
|
STIEFEL LABORATORI... |
00831160 |
31.12.2013 |
N |
|
|
STIEFEL LABORATOR... |
01633638 |
31.12.2013 |
N |
|
|
BLOCK DRUG |
|
- |
- |
$105,000 |
|
STAFFORD-MILLER LIMITED |
00318499 |
31.12.2014 |
N |
|
|
CELLZOME INC |
N/A |
- |
- |
|
|
CELLZOME LIMITED |
05001893 |
31.12.2013 |
N |
|
|
GLAXOSMITHKILNE INTERN... |
N/A |
- |
- |
|
|
GLAXOSMITHKLINE TRAD... |
IE406446 |
31.12.2013 |
N |
|
|
GLAXOSMITHKLINE SERVIC... |
01047315 |
31.12.2013 |
N |
£100,000,000£2,734,000,000 |
|
GLAXOSMITHKLINE BIOLOG... |
440872918 |
31.12.2013 |
N |
€2,798,325,283 |
|
GLAXOSMITHKLINE INTE... |
02298366 |
31.12.2014 |
N |
£100,000,000 |
|
GLAXOSMITHKLINE (NETHE... |
30153615 |
31.12.2006 |
N |
|
|
GLAXOSMITHKLINE HOLDIN... |
N/A |
- |
- |
|
|
GLAXOSMITHKLINE SL LP |
LP013718 |
- |
N |
|
|
GLAXOCHEM (UK) UNLIM... |
04299472 |
31.12.2014 |
N |
£100,000,000 |
|
GLAXOSMITHKLINE HOLDIN... |
04230101 |
31.12.2013 |
N |
|
|
GLAXOSMITHKLINE HOLDIN... |
05647873 |
31.12.2014 |
N |
|
|
GLAXOSMITHKLINE FINA... |
00242686 |
31.12.2014 |
N |
£100,000,000£65,023,000 |
|
SETFIRST LIMITED |
02332323 |
31.12.2014 |
N |
|
|
GLAXOSMITHKLINE I... |
06968741 |
31.12.2014 |
N |
|
|
GLAXOSMITHKLINE I... |
07089743 |
31.12.2014 |
N |
£100,000,000 |
|
GLAXOSMITHKLINE H... |
09163001 |
28.08.2014 |
N |
|
|
GLAXOSMITHKLINE C... |
09400298 |
- |
N |
|
|
GLAXOSMITHKLINE (... |
IE015513 |
31.12.2013 |
N |
|
|
GLAXOSMITHKLINE C... |
IE024797 |
31.12.2013 |
N |
|
|
GLAXOSMITHKLINE D... |
IE268666 |
31.12.2013 |
N |
|
|
GLAXOSMITHKLINE I... |
IE524787 |
31.12.2013 |
N |
€93,905,633 |
|
GLAXOSMITHKLINE C... |
08998608 |
31.12.2014 |
N |
|
|
GLAXOSMITHKLINE... |
08114550 |
31.12.2013 |
N |
£532,354,000 |
|
GLAXOSMITHKLINE... |
09237639 |
- |
N |
|
|
GLAXOSMITHKLINE... |
09237643 |
- |
N |
|
|
GLAXOSMITHKLINE... |
09237645 |
- |
N |
|
|
GLAXOSMITHKLINE... |
09299680 |
- |
N |
|
|
STIEFEL CONSUME... |
09416736 |
- |
N |
|
|
SMITHKLINE BEECHA... |
IE187383 |
31.12.2013 |
N |
€106,000 |
|
GLAXOSMITHKLINE IH... |
07257967 |
31.12.2014 |
N |
|
|
GLAXO GROUP LIMITED |
00305979 |
31.12.2013 |
N |
£112,671,000 |
|
MONTROSE FINE CHE... |
SC190635 |
31.12.2014 |
N |
|
|
GLAXO WELLCOME UK... |
00480080 |
31.12.2014 |
N |
|
|
ALLEN & HANBURY... |
00040209 |
31.12.2014 |
N |
|
|
GLAXO LABORATOR... |
00239893 |
31.12.2014 |
N |
|
|
GLAXO OPERATIONS... |
00711851 |
31.12.2013 |
N |
£649,934,000 |
|
GLAXOSMITHKLINE I... |
08283186 |
31.12.2013 |
N |
£1,394,125,000 |
|
GLAXOSMITHKLINE I... |
08283289 |
31.12.2013 |
N |
|
|
GLAXOSMITHKLINE... |
08283252 |
31.12.2013 |
N |
£610,857,000 |
|
GLAXOSMITHKLINE... |
07739397 |
31.12.2013 |
N |
£100,000,000£1,865,413,000 |
|
GLAXOSMITHKLI... |
08283222 |
31.12.2013 |
N |
£78,431,000 |
|
ACTION POTENTIAL... |
08603529 |
31.12.2014 |
N |
|
|
CLARGES PHARMACEU... |
00100583 |
31.12.2014 |
N |
|
|
DOMANTIS LIMITED |
03907643 |
31.12.2013 |
N |
£8,808,000 |
|
EDINBURGH PHARMAC... |
SC005534 |
31.12.2014 |
N |
|
|
GLAXOSMITHKLINE... |
IE531545 |
31.12.2013 |
N |
€30,113,371 |
|
GLAXOSMITHKLINE U... |
04310159 |
31.12.2013 |
N |
£1,507,094,000 |
|
GLAXOSMITHKLINE E... |
02433585 |
31.12.2013 |
N |
£2,159,178,000 |
|
GLAXOSMITHKLINE R... |
00835139 |
31.12.2013 |
N |
£1,007,830,000 |
|
MAXINUTRITION GRO... |
06445049 |
30.04.2011 |
Y |
|
|
MM MIDCO LIMITED |
06445050 |
30.04.2011 |
N |
|
|
MM BIDCO LIMITED |
06445051 |
30.04.2011 |
N |
|
|
MAXIMUSCLE... |
05127535 |
30.04.2011 |
N |
|
|
MAXINUTRI... |
03084288 |
30.04.2011 |
N |
|
|
MIXIS GENETICS LI... |
03225840 |
31.12.2014 |
N |
|
|
STAFFORD-MILLER (... |
IE379445 |
31.12.2013 |
N |
|
|
SMITHKLINE BEECHAM... |
02337959 |
31.12.2013 |
N |
£591,000,000 |
|
SMITH KLINE & FRE... |
00052207 |
31.12.2014 |
N |
|
|
BEECHAM GROUP P... |
00227531 |
31.12.2014 |
N |
|
|
SMITHKLINE BEECHA... |
00064836 |
31.12.2013 |
N |
|
|
ESKAYLAB LIMITED |
00099025 |
31.12.2014 |
N |
|
|
SMITHKLINE BEECHA... |
00190223 |
31.12.2014 |
N |
|
|
HORLICKS LIMITED |
00210281 |
31.12.2014 |
N |
|
|
SMITHKLINE BEECHA... |
00229017 |
31.12.2013 |
N |
£4,420,000 |
|
SMITHKLINE BEECHA... |
00494385 |
31.12.2014 |
N |
|
|
SMITHKLINE BEECHA... |
00503868 |
31.12.2014 |
N |
|
|
GLAXOSMITHKLINE C... |
00522215 |
31.12.2013 |
N |
£29,146,000 |
|
SMITHKLINE BEECHA... |
02552828 |
31.12.2014 |
N |
|
|
SMITHKLINE BEECHA... |
02860752 |
31.12.2014 |
N |
|
|
SMITHKLINE BEECHA... |
03425311 |
31.12.2013 |
N |
|
|
SMITHKLINE BEECHA... |
03425313 |
31.12.2013 |
N |
|
|
DEALCYBER LIMITED |
03541898 |
31.12.2014 |
N |
£14,625,000 |
|
GLAXOSMITHKLINE C... |
02258699 |
31.12.2014 |
N |
|
|
SMITHKLINE BEECHA... |
00302065 |
31.12.2014 |
N |
|
|
WELLCOME LIMITED |
01955498 |
31.12.2014 |
N |
|
|
SMITHKLINE BEECHA... |
03296131 |
31.12.2014 |
N |
|
|
WELLCOME FOUNDATI... |
00194814 |
31.12.2014 |
N |
|
|
CHARLES MIDGLEY... |
00162786 |
31.12.2014 |
N |
|
|
WELLCOME CONSUM... |
00263054 |
31.12.2014 |
N |
|
|
BURROUGHS WEL... |
00543757 |
31.12.2014 |
N |
|
|
WELLCOME CONSUM... |
02873615 |
31.12.2014 |
N |
|
|
SMITHKLINE & FRENCH B V |
N/A |
- |
- |
|
|
SMITHKLINE BEECHAM (... |
IE217028 |
31.12.2013 |
N |
|
|
STIEFEL LABORATORIES INC |
|
- |
- |
|
|
STIEFEL CANADA INC |
N/A |
- |
- |
|
|
Name |
Number |
Latest Key
Financials |
Turnover |
|
GLAXOSMITHKLINE |
300208407 |
31.12.2013 |
€121,069,141 |
|
SETFIRST (NO. 2) LIMITED |
FC025752 |
31.12.2008 |
|
|
GLAXO WELLCOME PRODUCTION |
410352777 |
31.12.2013 |
€312,327,399 |
|
GLAXOSMITHKLINE S.P.A. |
VR29640 |
31.12.2013 |
€845,972,860 |
|
GLAXOSMITHKLINE MANUFACTURING S.P.A. |
VR325375 |
31.12.2013 |
€154,757,470 |
|
LABORATOIRE GLAXOSMITHKLINE |
642041362 |
31.12.2013 |
€1,213,569,710 |
|
GROUPE GLAXOSMITHKLINE |
592052146 |
31.12.2013 |
|
|
GLAXOSMITHKLINE BIOLOGICALS |
338460017 |
31.12.2013 |
€129,982,183 |
|
SMITHKLINE BEECHAM HOLDINGS (UK)
LIMITED |
03890815 |
31.12.2009 |
|
|
GLAXOSMITHKLINE AKTIEBOLAG |
5562366343 |
31.12.2013 |
|
|
GLAXOSMITHKLINE OY |
01083784 |
31.12.2014 |
|
|
GLAXO PROPERTIES B.V. |
30102544 |
31.12.2013 |
|
|
GLAXOSMITHKLINE SANTE GRAND PUBLIC |
672012580 |
31.12.2013 |
€182,038,542 |
|
VIIV HEALTHCARE SAS |
413900382 |
31.12.2013 |
€146,262,453 |
|
MIXIS FRANCE |
339627234 |
31.12.2012 |
|
|
VIIV HEALTHCARE S.R.L. |
VR372785 |
31.12.2013 |
€112,437,795 |
|
GLAXOSMITHKLINE AS |
930606308 |
31.12.2013 |
642,884 KNOK |
|
GLAXOSMITHKLINE CONSUMER HEALTHCARE S.P.A |
MI598024 |
31.12.2013 |
€216,698,142 |
|
GLAXOSMITHKLINE INTERNATIONAL (LUXEMBOURG) S.À R.L. |
B73232 |
31.12.2013 |
-- |
|
GLAXOSMITHKLINE CONSUMER HEALTHCARE B.V. |
3314782 |
31.12.2013 |
€48,469,000 |
|
Name |
Current Directorships |
Previous Directorships |
|
CAROL BERESFORD |
0 |
4 |
|
CAROL BERESFORD |
0 |
4 |
|
DEREK DEVEREUX |
0 |
1 |
|
MICHAEL TYLER |
0 |
2 |
|
TRACY LOCKHART |
0 |
2 |
|
GREGOR MCNAB |
0 |
1 |
|
BELINDA DOLBEAR |
0 |
3 |
|
VINCENT CURTIN |
0 |
3 |
|
JIMMY WEMYSS |
0 |
1 |
|
PASCHAL PHELAN |
3 |
2 |
|
PADRAIC JOHN DOHERTY |
4 |
2 |
|
MICHAEL WILLISON |
0 |
2 |
|
Average Invoice
Value |
|
|
|
€3832.60 |
|
|
Invoices available |
|
|
|
40 |
|
|
Paid |
|
|
|
40 |
|
|
Outstanding |
|
|
|
0 |
|
|
Trade Payment Data is
information that we collect from selected
third party partners who send us
information about their whole sales |
|
|
|||
|
ledger. |
|
|
|
|
|
|
|
Within Terms |
0-30 Days |
31-60 Days |
61-90 Days |
91+ Days |
|
Paid |
20 |
9 |
4 |
4 |
3 |
|
Outstanding |
0 |
0 |
0 |
0 |
0 |
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.66.51 |
|
|
1 |
Rs.104.01 |
|
Euro |
1 |
Rs.76.27 |
INFORMATION DETAILS
|
Analysis Done by
: |
KAS |
|
|
|
|
Report Prepared
by : |
ASH |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess SC’s
credit risk and to set the amount of credit to be extended. It is calculated
from a composite of weighted scores obtained from each of the major sections of
this report. The assessed factors and their relative weights (as indicated
through %) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.